SI
GILD icon

Sofinnova Investments’s Gilead Sciences GILD Stock Holding History

Sofinnova Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-300,000
Closed -$19.4M – 69
2021
Q1 		$19.4M Buy
+300,000
New +$19.3M 1.17% 25
2020
Q2 		– Sell
-100,000
Closed -$7.48M – 83
2020
Q1 		$7.48M Buy
+100,000
New +$6.91M 0.69% 27

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments's GILD Position: Q2 2026 in Review

Sofinnova Investments opened a new position in Gilead Sciences (GILD) in Q2 2026: 343,100 shares worth $43.3M. The stake represents 2.24% of the portfolio and ranks #13 among its holdings. This is a return to the name: Sofinnova Investments previously reported a position in GILD as recently as Q3 2025.

Sofinnova Investments first reported a position in GILD in Q4 2018 and has held it in 8 quarters since. The position peaked at $139M in Q3 2025. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sofinnova Investments held 343,100 shares of Gilead Sciences worth $43.3M as of Q2 2026.
  • Gilead Sciences was a new Sofinnova Investments position in Q2 2026.
  • Gilead Sciences made up 2.24% of Sofinnova Investments's portfolio in Q2 2026, its #13 holding.
  • Sofinnova Investments first reported a position in Gilead Sciences in Q4 2018 and has held it in 8 quarters since.
  • Sofinnova Investments's Gilead Sciences position peaked at $139M in Q3 2025.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.